Join Lance Burrell for an insightful conversation with Dr. Gary Ulaner, as they discuss the role of nuclear medicine in breast cancer treatment and lesser-known breast cancer types.

Join Dr. Faraz Farhadi and Dr. Navid Hasani as they discuss solutions to recruiting nuclear medicine physicians and expanding the pipeline of trainees.

This podcast is brought to you by Lilly, member of the SNMMI Value Initiative Industry Alliance. Hosts Anupa Arora, MD and Anthony “Nino” Sireci, MD discuss a New Era in Alzheimer Diagnostics. This episode takes a focused look at high-impact topics shaping the future of Nuclear Medicine and Molecular Imaging, designed specifically for professionals driving value in the field. 

June is Alzheimer's and Brain Awareness month, join Phillip Kuo, MD, PhD as he delves into the history of neurodegenerative disorders and the progress nuclear medicine has made to help diagnose and treat diseases like dementia and Alzheimer’s. 

Join Bonnie Clarke, Senior Director of Research and Development at SNMMI, and Richard Wahl, MD, Mallinckrodt Institute of Radiology Professor, past president of SNMMI, and founder of the Mars Shot, as they talk about the Radiopharmaceutical Therapy Centers of Excellence (RPTCOE) program and see how nuclear medicine plays a key role in patient care. 

In this special American Heart Month episode, Lance Burrell—nuclear medicine technologist and SNMMI Research and Discovery imaging specialist—sits down with Dr. Richard Weinberg, MD, PhD, the Medical Director of Nuclear Cardiology at Northwestern’s Bluhm Cardiovascular Institute and President of the SNMMI Cardiovascular Council. Dr. Weinberg shares expert insights on the critical role of nuclear medicine in heart health, the latest advancements in nuclear cardiology, and the power of prevention in cardiovascular care.

This podcast is brought to you by GE HealthCare, an SNMMI Value Initiative member. 

This podcast asks about AI's promise in nuclear medicine in image acquisition, image reconstruction, post processing, computer diagnosis has been promising, but clinical adoption will require AI to provide a higher value compared to the standard of care. This podcast will ask question such as how can AI provide this improved bio nuclear medicine? What are some of the strategies that can help us with AI demonstrating clinical value? What are some of the initiatives that we can take as a society and as a community to strengthen this value, and how can we rally the community to take steps towards strengthening this value? 

This podcast is brought to you by GE HealthCare, an SNMMI Value Initiative member.  Hosts Zhiyong Lu, PhD and Jong Chul Ye, PhD speak about emerging territories in the broadening domain of Artificial Intelligence and learning about generative AI. Dr. Lu will speak the work he has done in AI in the context national language processing. Dr. Ye will speak on generative AI in imaging. 

This podcast is brought to you by United Imaging, co-chair of the SNMMI Value Initiative Industry Alliance. Hosts Munir Ghesani, MD, former President of SNMMI, co-chair of the Mars Shot Research Fund, and Stephen Lokitz, MD, a Nuclear Medicine physicist and Executive Director and Director of Imaging Sciences at the Center for Molecular Imaging and Therapy, or CMIT, discuss nuclear medicine procedures performed and their plans for the future.

This episode is a recorded presentation delivered by Robert Gatenby, MD from the Moffitt Cancer Center during the opening plenary at the SNMMI 2024 Artificial Intelligence Summit, "AI In Action" held Feb 29 - March 1, 2024.  Dr. Gatenby has used evolutionary dynamics models to develop an adaptive therapy approach for the treatment of cancer which he describes during his talk.  Join this podcast and discover an innovative and effective approach to treating cancer – the use of evolutionary biology, mathematical oncology and radiopharmaceutical therapy.  

Drs. Jon McConathy, David A. Wolk, and Illya M. Nasrallah provide an update and information about neuro imaging related to Alzheimer's disease, particularly amyloid and tau imaging.

Dr. Tina Buehner, Dr. Remo George, Jose “Freddy” Gonzalez, and Erika Padilla-Morales discuss the importance of research in advancing nuclear medicine and the impact of research on patient care and the future of molecular imaging.

Dr. Stephen A. Graves and Dr. Andrei Iagaru discuss the opportunities, threats, challenges, trends, and lessons learned regarding radiopharmaceutical therapy with moderator Dr. Phillip J. Koo.

Dr. Jean-Mathieu Beauregard and Dr. Carlos Uribe discuss the present, future, and implications of dosimetry with moderator Dr. John Sunderland.

In part 2 of a conversation with Dr. Stephen Graves and Dr. Benjamin Auer, our two experts continue their discussion on quantitative SPECT, its place in regards to PET, requirement, and current status.

In part 1 of a conversation with Dr. Stephen Graves and Dr. Benjamin Auer, our two experts discuss quantitative SPECT, its place in regards to PET, requirement, and current status.

Umar Mahmood, MD, PhD, and Andrei Iagaru, MD—the inaugural recipient of the Sam Gambhir Trailblazer Award—discuss Dr. Gambhir's life and legacy, including personal and professional recollections. Dr. Iagaru also shares his thoughts on the future of nuclear medicine therapies, what keeps him motivated, and more.

This new SNMMI award was created in memory of Sanjiv 'Sam' Gambhir, MD, PhD, who passed away in July 2020. He was Professor and Chair of Radiology at the Stanford School of Medicine and an internationally recognized pioneer in molecular imaging. The Sam Gambhir Trailblazer Award honors outstanding achievement in excellence in transformative research (either basic science, translational science or clinical science) and exceptional mentorship for mid-career professionals.

This episode features Simon Cherry, PhD, discussing his recent 2022 Annual Meeting Cassen Award Lecture and more in a wide-ranging conversation with SNMMI President, Munir Ghesani, MD.

In his lecture—A Matter of Time—at the SNMMI 2022 Annual Meeting, Cassen Award Winner Simon Cherry, PhD , explored time, and its role in nuclear medicine, from historical developments occurring over decades, to technologies that can detect photons with a precision of tens of picoseconds. Inspired by the groundbreaking ideas of Benedict Cassen and others, Dr. Cherry charted the journey from the past and into the future to create the ultimate imaging devices for studying the body and its many interacting systems

The Benedict Cassen Prize is awarded by the Education and Research Foundation (ERF) for Nuclear Medicine and Molecular Imaging in recognition of outstanding achievement and work leading to a major advance in nuclear medicine science.

Heather Jacene, MD, SNMMI Scientific Program Chair, sits for a conversation with E.G. Elisabeth de Vries, MD, PhD—the SNMMI 2022 Annual Meeting Henry N. Wagner, Jr., MD, Lectureship Speaker—for a preview of her lecture: Seeing the Light with Molecular Imaging for Systemic Cancer Treatment Decisions.